DRD2 and neoplasm: Major studies showed that DA acting via D2R inhibits tumor angiogenesis by suppressing the actions of vascular permeability factor/vascular endothelial growth factor A on tumor endothelial cells and bone marrow-derived endothelial progenitor cells [123,124,125].